$TEM

4 theses

bullish 25%neutral 0%bearish 75%

Avg return (1w)

+1.9%

Win rate (1w)

100% (1 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Aug 24, 1:28 PM ET

$TEMSEC Form 4bearish

Fukushima Ryan · CEO, Data at Tempus AI, Inc. · 11d agono track record yet

Sold 41,095 @ $49.61 avg · $2,038,723 · 2026-08-18

Form 4: Fukushima Ryan sold TEM

Fukushima Ryan (CEO, Data at Tempus AI, Inc.) reported an open-market sale of 41,095 shares of TEM at an average $49.61, roughly $2,038,723, in a Form 4 filed 2026-08-20.

At post $66.65Now $67.34+1.0% since postedas of Aug 24, 1:28 PM ET

1d+9.1%

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$TEMSEC Form 4bearish

LEFKOFSKY ERIC P · CEO and Chairman at Tempus AI, Inc. · 11d agono track record yet

Sold 132,591 @ $49.61 avg · $6,577,840 · 2026-08-18

Form 4: LEFKOFSKY ERIC P sold TEM

LEFKOFSKY ERIC P (CEO and Chairman at Tempus AI, Inc.) reported an open-market sale of 132,591 shares of TEM at an average $49.61, roughly $6,577,840, in a Form 4 filed 2026-08-20.

At post $66.65Now $67.34+1.0% since postedas of Aug 24, 1:28 PM ET

1d+9.1%

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$TEMSEC Form 4bearish

Bartolucci Ryan M · Chief Accounting Officer at Tempus AI, Inc. · 11d agono track record yet

Sold 6,175 @ $49.61 avg · $306,342 · 2026-08-18

Form 4: Bartolucci Ryan M sold TEM

Bartolucci Ryan M (Chief Accounting Officer at Tempus AI, Inc.) reported an open-market sale of 6,175 shares of TEM at an average $49.61, roughly $306,342, in a Form 4 filed 2026-08-20.

At post $66.65Now $67.34+1.0% since postedas of Aug 24, 1:28 PM ET

1d+9.1%

3d—

1w—

1m—

3m—

6m—

1y—

View filing on SEC.gov →

$TEMr/wallstreetbetsDDbullish

u/Chidoba · 96d ago1 prior · awaiting results

Long TEM $120C exp Jan 1

The next AI rotation - from infrastructure to data reservoirs

Tempus owns continuously updated proprietary clinical datasets and physician interaction workflows that are essential for training medical AI models. The company is positioned as a strategic AI data supplier in healthcare, with the data business representing a multi-billion dollar opportunity.

At post $51.29Now $67.34+31.3% since postedas of Aug 24, 1:28 PM ET

1d-1.6%

3d-1.6%

1w+1.9%

1m+9.5%

3m—

6m—

1y—

original post →

End of results.